Macroalgal activity against fungal urinary tract infections: in vitro screening and evaluation study
- 36 Downloads
Application of antimicrobial botanical extracts and other natural products is receiving increasing attention. The present study aimed to evaluate the antifungal activities of some macroalgae collected from Alexandria beach, Egypt for treatment of fungal urinary tract infections (UTIs). Methanol extracts of Ulva lactuca showed the highest recorded antifungal activity against Aspergillus flavus and Aspergillus niger, while Enteromorpha linza showed the highest antifungal activity against Candida tropicalis. In addition, methanol extracts of both macroalgae showed a significant urease inhibition of the corresponding fungi. Lineweaver–Burk plots indicated a reversible non-competitive mechanism for U. lactuca extract, whereas E. linza extract showed a reversible competitive inhibition. Fatty acids profile of methanol extracts of U. lactuca and E. linza showed predominance of octadecanoic acid and hexadecanoic acid (48.4% and 62.9% of total fatty acids, respectively). In addition, GC/MS results showed significant proportions of the biologically active compounds; benzodioxoles such as piperonylbutoxide, organochlorines such as p,p’-dichlorodiphenyltrichloroethane (DDT) in U. lactuca and phytosterols such as stigmastan derivatives in E. linza. The present study represents an advancement in the knowledge of the chemistry and antifungal potential of macroalgae against UTIs and offers promising trend for drug discovery from marine macroalgae.
KeywordsAntifungal Biological activity Seaweeds Urease inhibition UTIs
The authors are thankful to the Head of Urology and Venereology Department, Tanta University Hospital, Tanta, Egypt for providing the necessary help for carrying out the research work.
NAZ and SME contributed in experimental design and raw data collection and drawing figures/tables besides writing the draft of the paper. AEA organized the data, critical reading of the manuscript and submitted the paper to the journal. All authors have read and approved the manuscript in its present form.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval and consent to participate
All study procedures were implemented at Tanta University and urine sample collection was approved by the Institutional Ethics Committee.
- Abd Elmegeed D, Ghareeb D, Elsayed M, El-Saadani M (2014) Phytochemical constituents and bioscreening activities of green algae (Ulva Lactuca). Int J Agric Policy Res 2:373–378Google Scholar
- Aleem A (1993) The marine algae of Alexandria. Egyptian Books House, EgyptGoogle Scholar
- Christensen W (1946) Urea decomposition as a means of differentiating Proteus and Paracolon cultures from each other and from Salmonella and Shigella types. J Bacteriol 52:461–466Google Scholar
- Ertürk O, Tas B (2011) Antibacterial and antifungal effects of some marine algae. Kafkas Univ Vet Fak Derg 17:S121–S124Google Scholar
- Klich M (2002) Identification of common Aspergillus species. Centraalbureau voor Schimmelculture, Utrecht, NetherlandGoogle Scholar
- Kolsi R, Frikha D, Jribi I, Hamza A, Feki L, Belghith K (2015) Screening of antibacterial and antifongical activity in marine macroalgae and Magnoliophytea from coast of Tunisia. Int J Pharm Pharm Sci 7:47–51Google Scholar
- Kurtzman C, Fell J, Boekhout T (2011) The yeasts, fifth edition: a taxonomic study, 5th edn. Elsevier Science Publishers, AmsterdamGoogle Scholar
- Manilal A, Sujith S, Selvin J, Shakir C, Kiran G (2009) Antibacterial activity of Falkenbergia hillebrandii (Born) from the Indian coast against human pathogens. Phyton 78:161–166Google Scholar
- Mobley H, Island M, Hausinger R (1995) Molecular biology of microbial urease. Microbiol Mol Biol Rev 59:451–480Google Scholar
- Pfaller M, Diekema D, Messer S, Boyken L, Hollis R (2003) Activities of fluconazole and voriconazole against recent clinical isolate of Candida species determined by broth microdilution, disc diffusion and Etest method: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol 41:1440–1446CrossRefGoogle Scholar